diphenhydramine hydrochloride has been researched along with Leucocythaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, BB; Ahn, KS; Sung, B | 1 |
| Gugler, E | 1 |
2 other study(ies) available for diphenhydramine hydrochloride and Leucocythaemia
| Article | Year |
|---|---|
Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway.
Topics: Alkaloids; Antitussive Agents; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; I-kappa B Kinase; Jurkat Cells; Leukemia; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Noscapine; Signal Transduction | 2010 |
[Acquired thrombopathies caused by defect of the platelet release reaction].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antidepressive Agents; Antitussive Agents; Autoimmune Diseases; Blood Platelet Disorders; Disseminated Intravascular Coagulation; Glycogen Storage Disease; Heart Defects, Congenital; Histamine H1 Antagonists; Humans; Leukemia; Scurvy; Uremia | 1978 |